Zobrazeno 1 - 10
of 54
pro vyhledávání: '"K A Petrosyan"'
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 2S (2024)
As technology improves, the number of transcatheter aortic valve implantation (TAVI) procedures performed is steadily increasing. Due to the comparable outcomes with surgical treatment of aortic stenosis, TAVI is increasingly being performed in a gro
Externí odkaz:
https://doaj.org/article/f954b7f88ded40a9a38082d9162d356d
Autor:
K. V. Petrosyan, A. V. Abrosimov, E. S. Goncharova, N. I. Bulaeva, B. Sh. Berdibekov, E. Z. Golukhova
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 4S (2023)
Aim. To evaluate the accuracy of virtual stenting in predicting the physiological effect of percutaneous coronary intervention (PCI) for multilevel coronary artery disease (CAD).Material and methods. In order to define PCI strategy, 34 patients with
Externí odkaz:
https://doaj.org/article/0c503f1c8ce74cc8a9d62a561ac9a784
Publikováno v:
Неотложная медицинская помощь, Vol 9, Iss 4, Pp 677-683 (2021)
A clinical observation of an integrated approach to surgical reconstruction of multisystem trauma complications is presented. A man came to the Department of Reconstructive Surgery with the complication of a multisystem injury as a result of a fall i
Externí odkaz:
https://doaj.org/article/3a4e12df97cd4880a5fdbd8d62071f00
Autor:
E. V. Borodavina, P. A. Isaev, A. Yu. Shurinov, P. O. Rumyantsev, V. V. Krylov, K. M. Petrosyan, A. D. Kaprin, S. A. Ivanov, S. O. Podvyaznikov, I. S. Romanov, A. M. Mudunov, K. Yu. Slashchuk, R. S. Zhikhorev, M. V. Volkonsky, R. M. Chagova, I. R. Suslova, A. I. Khryapa, A. Kh. Lepshokova, N. L. Fadeeva, A. R. Safarova, L. P. Kaleykina, E. V. Lymar, E. M. Chernyakova, O. A. Snezhko, A. E. Zinkovskaya, F. F. Mufazalov, E. S. Kuzmina, Yu. V. Druzhinina, Sh. I. Musin, M. R. Mukhitova, A. I. Khasanova, S. Z. Safina, S. L. Kirienko
Publikováno v:
Опухоли головы и шеи, Vol 10, Iss 1, Pp 65-72 (2020)
Background. The implementation of tyrosine kinase inhibitors into clinical practice improved treatment outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC). Lenvatinib is recommended as a first-line drug for these p
Externí odkaz:
https://doaj.org/article/90b3f88358a64191b3df59c14333279c
Autor:
V. V. Krylov, N. S. Legkodimova, T. Yu. Kochetova, V. M. Petriev, M. A. Sigov, V. K. Tishchenko, A. I. Pronin, A. Yu. Shurinov, K. M. Petrosyan, O. N. Spichenkova, O. B. Karyakin, V. A. Biryukov, V. F. Stepanenko, O. P. Vlasova, P. V. Shegaj, S. A. Ivanov, A. D. Kaprin
Publikováno v:
Diagnostic radiology and radiotherapy. 13:75-85
INTRODUCTION: The results of studies of clinical potential of a new domestic radiopharmaceutical 177Lu-DOTA-PSMA in patients with metastatic castration-resistant prostate cancer are presented in this article.OBJECTIVE: The pharmacokinetics, safety an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdb57b61a11e365eb7351e7acaa6c859
https://doi.org/10.22328/2079-5343-2022-13-4-75-85
https://doi.org/10.22328/2079-5343-2022-13-4-75-85
Autor:
K. M. Petrosyan, N. V. Severskaya, D. N. Derbugov, A. A. Kuril'chik, N. V. Zhelonkina, A. V. Dement'ev, E. I. Kupriyanova, G. A. Davydov, A. D. Kaprin, V. N. Galkin, S. A. Ivanov
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 5, Iss 1, Pp 96-105 (2018)
Hyperparathyroidism is one of the most common endocrinopathies. This disease leads to a violation of phosphorus-calcium metabolism and the washing out of calcium from bone tissue. Breach of the skeleton’s structure in hyperparathyroidism is often m
Externí odkaz:
https://doaj.org/article/19aaff46f9344d8f85fd5d26b9627086
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 3, Iss 2, Pp 43-47 (2015)
Aim. To evaluate the effect of imidasoline agonist, rilmenidine (Albarel), on 24-hour blood pressure (BP) profile and autonomic regulation of cardiovascular system in young patients with arterial hypertension (HT) and exogenous constitutional obesity
Externí odkaz:
https://doaj.org/article/7360040a3c0d452c8ff92d511df725b6
Autor:
A. A. Rodichev, T. Yu. Kochetova, K. M. Petrosyan, V. V. Krylov, T. M. Geliashvili, E. V. Borodavina, P. I. Garbuzov, A. Yu. Shurinov
Publikováno v:
Diagnostic radiology and radiotherapy. 11:20-24
The latest recommendations of the American Thyroid Association have caused serious disagreements between the nuclear medicine and endocrinologist communities regarding the radioactive iodine use. In 2018 eighteen experts from 8 countries and 4 leadin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da3a8f456388c8c86aa1c7445e551853
https://doi.org/10.22328/2079-5343-2020-11-3-20-24
https://doi.org/10.22328/2079-5343-2020-11-3-20-24
Autor:
T Yu. Kochetova, V. V. Krylov, K. M. Petrosyan, O. B. Karyakin, V. A. Biryukov, B. Ya. Alekseev, V. B. Matveev, S. A. Ivanov, A. D. Kaprin
Publikováno v:
Onkourologiâ, Vol 16, Iss 1, Pp 114-123 (2020)
Radiopharmaceuticals previously used to treat patients with metastatic castrate-resistant prostate cancer and skeletal metastases were positioned as means to suppress pain, reduce analgesics consumption and improve the quality of life. They were usua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04d251464b56b87861c8f7cb52a5acfd
https://doi.org/10.17650/1726-9776-2020-16-1-114-123
https://doi.org/10.17650/1726-9776-2020-16-1-114-123
Autor:
A. I. Khryapa, E. M. Chernyakova, F. F. Mufazalov, E. V. Lymar, S. A. Ivanov, K. Yu. Slashchuk, N. L. Fadeeva, R. M. Chagova, V. V. Krylov, A. R. Safarova, A. M. Mudunov, S. Z. Safina, M. R. Mukhitova, A. I. Khasanova, S. O. Podvyaznikov, K. M. Petrosyan, I. R. Suslova, R. S. Zhikhorev, A. Kh. Lepshokova, P. A. Isaev, S. L. Kirienko, Yu. V. Druzhinina, I. S. Romanov, E. S. Kuzmina, Andrey Kaprin, Sh. I. Musin, O. A. Snezhko, A. Yu. Shurinov, L. P. Kaleykina, A. E. Zinkovskaya, Pavel O. Rumyantsev, M. V. Volkonsky, E. V. Borodavina
Publikováno v:
Opuholi Golovy i Šei, Vol 10, Iss 1, Pp 65-72 (2020)
Background. The implementation of tyrosine kinase inhibitors into clinical practice improved treatment outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC). Lenvatinib is recommended as a first-line drug for these p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a048aaf0f080825f30978d7d8770c6d6
https://ogsh.abvpress.ru/jour/article/view/478
https://ogsh.abvpress.ru/jour/article/view/478